Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
2
67%
Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 42 (66.7%)

Trials by Status

withdrawn133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnearly_phase_1

Relapse Prevention in Stimulant Use Disorder

NCT04553263
unknownphase_4

A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery

NCT04587843
unknownphase_4

Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.

NCT04589130

Clinical Trials (3)

Showing 3 of 3 trials
NCT04553263Early Phase 1

Relapse Prevention in Stimulant Use Disorder

Withdrawn
NCT04587843Phase 4

A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery

Unknown
NCT04589130Phase 4

Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3